---
title: "CX 2025: Bioresorbable scaffold technology has “potential to be a new paradigm for femoropopliteal endovascular intervention”"
date: "2025-04-23T22:09:08.000Z"
publishedDate: "23 avril 2025"
summary: "In Wednesday&#8217;s peripheral arterial programme, which hosted several podium-first presentations, lower limb drug-eluting technologies took centre stage—signalling a potential shift in the treatment paradigm for chronic limb-threatening ischaemia (CLTI). Investigators shared compelling new data from studies ranging from first-in-human trials to large-scale registries, which vie to redefine durability and safety, as well as cost-effectiveness, in [&#8230;] The post CX 2025: Bioresorbable scaffold technology has &#8220;potential to be a new paradigm for femoropopliteal endovascular intervention&#8221; appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/cx-2025-bioresorbable-scaffold-technology-has-potential-to-be-a-new-paradigm-for-femoropopliteal-endovascular-intervention/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-04-23-cx-2025-bioresorbable-scaffold-technology-has-potential-to-be-a-new-paradigm-for-femoropopliteal-endovascular-intervention"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/04/CX-Daily-News-2-cover.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/cx-2025-bioresorbable-scaffold-technology-has-potential-to-be-a-new-paradigm-for-femoropopliteal-endovascular-intervention/"
---

![CX 2025: Bioresorbable scaffold technology has “potential to be a new paradigm for femoropopliteal endovascular intervention”](https://vascularnews.com/wp-content/uploads/sites/7/2025/04/CX-Daily-News-2-cover.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/cx-2025-bioresorbable-scaffold-technology-has-potential-to-be-a-new-paradigm-for-femoropopliteal-endovascular-intervention/*

## L’essentiel

In Wednesday&#8217;s peripheral arterial programme, which hosted several podium-first presentations, lower limb drug-eluting technologies took centre stage—signalling a potential shift in the treatment paradigm for chronic limb-threatening ischaemia (CLTI). Investigators shared compelling new data from studies ranging from first-in-human trials to large-scale registries, which vie to redefine durability and safety, as well as cost-effectiveness, in [&#8230;] The post CX 2025: Bioresorbable scaffold technology has &#8220;potential to be a new paradigm for femoropopliteal endovascular intervention&#8221; appeared first on Vascular News .

## Lien source

https://vascularnews.com/cx-2025-bioresorbable-scaffold-technology-has-potential-to-be-a-new-paradigm-for-femoropopliteal-endovascular-intervention/
